Publication | Open Access
Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status
44
Citations
26
References
2011
Year
Our data suggest that chemotherapy of MHC class I-deficient tumours with 5AC combined with immunotherapy is an attractive setting in the treatment of MHC class I-deficient tumours.
| Year | Citations | |
|---|---|---|
Page 1
Page 1